Delibera del 30 Dicembre, n. 572 [file.pdf] OGGETTO: “A randomized, double blind, placebo controller, parallel group trial for assessing the clinical benefit of Dronedarone 400 mg BID on top of standard therapy in patients with permanent atrial fibrillation and additional risk factors”
SOGGETTO PROMOTORE: SANOFI- AVENTISDettaglio Delibera del 30 Dicembre, n. 572